3355 results

World Heart Day 2021 - Pandemic and heart diseases: lessons learnt for the future

27 Sep 2021

Giulio Stefanini and Emanuele Barbato take the opportunity of World Heart Day to review the impact of the Covid-19 pandemic on cardiovascular care at a time when the pandemic has highlighted the gaps between different health systems.

Author

Giulio Stefanini

Author

Emanuele Barbato

Giant right coronary artery aneurysm unmasked in the setting of STEMI: killing two birds with one stone

09 Apr 2021

Consult this Twitter case from Ricardo Sanz: an 80-year-old man presenting with inferior STEMI, primary PCI being complicated by the presence of a giant coronary aneurysm in the RCA that hindered the advancement of wires and material towards a small and hidden entry point. Creative off-label...

Author

Ricardo Sanz-Ruiz

We CARE about hearts - EuroPCR 2022

19 May 2022

The aims of We CARE are to rebuild patient confidence and help stakeholders provide effective and timely cardiac care through knowledge, education and training.

Author

Christoph Naber

First Patient Enrolled in SELUTION SLR IDE BTK Study

08 Jun 2022

MedAlliance SELUTION SLR is the first DEB to receive coronary de novo IDE Aapproval , its Fourth FDA IDE DEB approval

10 Jan 2023

First US Patient Enrolled in SELUTION SLR IDE Peripheral Study

22 Aug 2022

MedAlliance SELUTION SLR Receives Second FDA IDE Approval

09 Aug 2022

EuroPCR 2022 – Local Pods

Local Pods are a great way to follow #EuroPCR with a group of local peers who are not in a position to travel to France. They also allow the programme to be adapted to meet regional educational needs.

First patient enrolled in Erectile Dysfunction prospective randomized study with SELUTION SLR

09 Sep 2022

POPular PAUSE TAVI - Continuation or interruption of oral anticoagulation during TAVI?

02 Sep 2024

Luis Ortega-Paz provides his take on the POPular PAUSE TAVI trial presented by Dirk Jan van Ginkel at the ESC Congress 2024 in London.

Author

Luis Ortega-Paz

ESC/EACTS Valvular Heart Disease Guidelines 2021: updates from the 2017 Guidelines

29 Aug 2021

There has been significant expansion in the field of structural heart diseases in the last couple of years, generating an extensive body of evidence and warranting an update to the 2017 Guidelines. Mirvat Alasnag provides an analysis of the updates included in this new document - a joint...

Author

Mirvat Alasnag

We CARE in 2023: Measuring the pandemic’s impact and developing tools to build resilience for the future

18 May 2023

The COVID-19 pandemic caused huge disruption to healthcare services and dramatically reduced hospital admissions for MI.1 In response, the We CARE initiative was created from a collaboration between PCR and Stent – Save a Life! to rebuild patient confidence in pursuing timely medical treatment and to help...

MedAlliance SELUTION SLR Receives Coronary FDA IDE Approval

24 Oct 2022

Restriction in supra-annular transcatheter heart valve leaflet mobility during coronary access after valve-in-valve TAVI

05 Apr 2022

This Image in Interventional Cardiology highlights how patient-specific ex vivo simulations offer physicians the opportunity to observe and evaluate the potential in vivo impact of different techniques particularly for complex structural heart interventions.

MedAlliance to be acquired by Cordis

18 Oct 2022

COVID-19: Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

07 Jan 2021

Examination of the study methodology and results according to the PICOT principle, SWOT analysis and real-world applicability

MedAlliance acquired by Cordis for up to USD 1.135 billion

02 Oct 2023

COVID-19 vaccines: Burning questions from the community and real-world applicability

13 Jan 2021

View a number of questions of interest to the interventional cardiovascular community, as well as the real-world applicability of COVID-19 vaccine trials.

Insights from the Corevalve US Pivotal and SURTAVI trials

05 Apr 2022

Pierre Deharo and Giuseppe Di Gioia provide their take on this analysis of the 5 years incidence, outcomes and predictors of hemodynamic SVD in patients undergoing TAVI and surgery from the Corevalve US Pivotal and SURTAVI trials.

Author

Pierre Deharo

Author

Giuseppe Di Gioia

PARTNER 3: weighing the comparative costs and savings of TAVI versus SAVR in low-risk patients with severe aortic stenosis

07 Nov 2021

Professor David J. Cohen presented the results of the economic outcomes of the PARTNER 3 trial on Friday, 5 November, in the Late-Breaking Trial session of the Transcatheter Cardiovascular Therapeutics Congress 2021. Giuseppe Biondi-Zoccai provides his analysis of this study.

Author

Giuseppe Biondi-Zoccai